Gregory R Bluemling
5PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.Stephen R Welch, Jessica R Spengler, Jonna B Westover
|Dec 02, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.Julien Sourimant, Carolin M Lieber, Megha Aggarwal
|Feb 09, 2021
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.Angela Wahl, Lisa E Gralinski, Claire E Johnson
|Apr 08, 2020
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.Timothy P Sheahan, Amy C Sims, Shuntai Zhou
|Oct 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.Mart Toots, Jeong-Joong Yoon, Robert M Cox
Pageof 1
Frequent Collaborators
3 joint publications
Zachary Sticher
3 joint publications
George R Painter
2 joint publications
Jeong-Joong Yoon
2 joint publications
Ralph S Baric
2 joint publications
Richard K Plemper
2 joint publications
Kenneth H Dinnon
1 joint publications
Mart Toots
1 joint publications
Roland Plesker
1 joint publications
Alec H Barrena
1 joint publications
Ryan C Shean
